RT Journal Article
SR Electronic
T1 ▾Lisinopril - another ACE inhibitor
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 31
OP 32
DO 10.1136/dtb.27.8.31
VO 27
IS 8
YR 1989
UL http://dtb.bmj.com/content/27/8/31.abstract
AB Lisinopril (Carace - MSD, Zestril - ICI) has joined captopril and enalapril1 as the third inhibitor of angiotensin-converting enzyme (ACE), for use in hypertension and heart failure. Advantages claimed for lisinopril are that it is not a pro-drug, its once daily dosage and its ability “to retain that zest for life” during antihypertensive therapy.